Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Spellberg, Brad"'
Autor:
Spellberg B; Division of General Internal Medicine, Los Angeles Biomedical Research Institute, Harbor-University of California Los Angeles (UCLA) Medical Center, Torrance, CA, USA. bspellberg@labiomed.org, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2012 Mar; Vol. 67 (3), pp. 715-22. Date of Electronic Publication: 2011 Sep 20.
Autor:
Ibrahim AS; Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles Medical Center, Torrance, CA 90502, USA. ibrahim@labiomed.org, Gebremariam T, French SW, Edwards JE Jr, Spellberg B
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2010 Feb; Vol. 65 (2), pp. 289-92. Date of Electronic Publication: 2009 Nov 26.
Autor:
Ibrahim AS; Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles Medical Center, Torrance, 90502, USA. ibrahim@labiomed.org, Gebremariam T, Schwartz JA, Edwards JE Jr, Spellberg B
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2009 Feb; Vol. 53 (2), pp. 772-5. Date of Electronic Publication: 2008 Oct 20.
Autor:
Reed C; Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor, University of California at Los Angeles Medical Center, Torrance, CA, USA., Bryant R, Ibrahim AS, Edwards J Jr, Filler SG, Goldberg R, Spellberg B
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2008 Aug 01; Vol. 47 (3), pp. 364-71.
Autor:
Ibrahim AS; Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California--Los Angeles Medical Center, Torrance, CA 90502, USA. ibrahim@labiomed.org, Gebremariam T, Husseiny MI, Stevens DA, Fu Y, Edwards JE Jr, Spellberg B
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2008 Apr; Vol. 52 (4), pp. 1573-6. Date of Electronic Publication: 2008 Jan 28.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2006 Aug; Vol. 50 (8), pp. 2895-6.
Autor:
Spellberg B; Division of Infectious Diseases, Harbor-UCLA Research and Education Institute, St. John's Cardiovascular Research Center, 1124 West Carson St., Torrance, CA 90502, USA., Fu Y, Edwards JE Jr, Ibrahim AS
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2005 Feb; Vol. 49 (2), pp. 830-2.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2004 Jan 15; Vol. 38 (2), pp. 304-5; author reply 306-7.
Autor:
Ibrahim AS; Harbor-UCLA Research and Education Institute, Torrance, California 90502. UCLA School of Medicine, Los Angeles, California 90024, USA. Ibrahim@HUMC.EDU, Avanessian V, Spellberg B, Edwards JE Jr
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2003 Oct; Vol. 47 (10), pp. 3343-4.
Autor:
Ibrahim, Ashraf S., Bowman, Joel C., Avanessian, Valentina, Brown, Keturah, Spellberg, Brad, Edwards, John E., Douglas, Cameron M.
Rhizopus oryzae is the most common cause of zygomycosis, a life-threatening infection that usually occurs in patients with diabetic ketoacidosis. Despite standard therapy, the overall rate of mortality from zygomycosis remains50%, and new strategies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de909a8deb59b9aa41fbb2ffc3e7789e
https://europepmc.org/articles/PMC547300/
https://europepmc.org/articles/PMC547300/